EP Patent
EP2679590A1 — Processes for the Preparation of Sitagliptin and Pharmaceutically acceptable Salts thereof
Assigned to Dr Reddys Laboratories Ltd · Expires 2014-01-01 · 12y expired
What this patent protects
A process for the preparation of sitagliptin of the formula II or a pharmaceutically acceptable salt thereof.
USPTO Abstract
A process for the preparation of sitagliptin of the formula II or a pharmaceutically acceptable salt thereof.
Drugs covered by this patent
- Steglatro (ERTUGLIFLOZIN) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.